I have no doubt that Axim has "built the better (if not best) mouse trap" for running these tests, and when the market realizes this, AXIM is going to infinity and beyond.
There are so many places that these tests can be inserted in order to cut down on time, complexity, and cost when it comes to diagnosis.
Add to that that the platform is easily expandible once the initial reader is purchased (as for instance, MMP-9).
I am willing to bet that everyone who has been holding AXIM to date wishes they had more powder available at these ridiculously low prices...
My posts are merely my unprofessional opinion and should NEVER be seen as or used as investment advice,